Neuropathic Pain
📧 Sign up to get email alerts when something new happens for Neuropathic Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury. [Phase 3]
Pfizer-sponsored Phase 3 trial assessing long-term safety and efficacy of pregabalin for neuropathic pain after spinal cord injury has compl…
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain [Phase 2]
Phase 2 trial evaluating NS1209 with lidocaine for peripheral neuropathic pain has completed.
-
CLINICAL_TRIALS trial_result · 2007-09-21Clinical Trial Update: Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome [Phase 4]
This Phase 4 study evaluated short- and long-term exposure to time-varying pulsed electromagnetic fields in patients with refractory carpal …
-
CLINICAL_TRIALS research · 2007-09-05Clinical Trial Update: Brain Activation During Thermal Stimulation in Neuropathic Pain
This clinical trial update describes a study examining brain activation during thermal stimulation in individuals with neuropathic pain, spo…
-
FDA label_change · 2007-07-03FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for Nortriptyline hydrochloride from Dr. Reddy's Laboratories, resulting in labeling changes for the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-06-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Amitriptyline hydrochloride from Sandoz Inc., enabling regulatory clearance for this generic pro…
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Efficacy of Valproate in Peripheral Neuropathic Pain [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating valproate for neuralgia and peripheral neuropathic pain was terminated.
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: Effects of Pregabalin on Mechanical Hyperalgesia [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating the effects of pregabalin on mechanical hyperalgesia and neuropathic…
-
CLINICAL_TRIALS trial_result · 2007-01-11Clinical Trial Update: Efficacy of Cortex Stimulation in Neuropathic Pain [Phase 2]
A Phase 2 study evaluating cortex stimulation for neuropathic pain was terminated. The update reports efficacy outcomes from the trial.
-
CLINICAL_TRIALS trial_result · 2007-01-01Clinical Trial Update: Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain. [Phase 3]
Pfizer completed a Phase 3 study assessing the long-term safety and efficacy of pregabalin in adults with chronic neuropathic pain.
-
FDA label_change · 2006-12-07FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
FDA approved a supplemental application for gabapentin—specifically a granule formulation—from Granules Pharmaceuticals Inc.
-
FDA approval · 2006-05-03FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for Neurontin (gabapentin) submitted by Parke-Davis Div of Pfizer Inc.